Miriam Schulze BAYOOMED

Miriam Schulze is the CEO of BAYOOMED GmbH, a leading company in the field of medical software development for MedTech, LifeScience, and pharmaceutical industries. She holds a background in computer science from Dresden and has accumulated over 14 years of experience in the medical technology sector. Her expertise spans across software engineering, quality management, risk management, and technical documentation, particularly in the development of safety-critical medical software and mobile medical apps compliant with IEC 62304. Throughout her career, Miriam Schulze has been instrumental in driving innovation within BAYOOMED, focusing on digital health technologies such as Clinical Decision Support Systems (CDSS) and reimbursable digital health applications (DiGA). She is recognized for her strategic leadership in integrating cutting-edge technologies with healthcare solutions, emphasizing patient outcomes and compliance with regulatory standards. Her work includes significant contributions to the fields of Diabetes Care, Women's Health and many other therapuetic areas where she has guided the product lifecycle from conception to CE marking and FDA approval of digital health applications. Miriam Schulze is also a noted speaker at conferences, where she shares insights on the challenges and innovations in medical software development, emphasizing the importance of documentation, and regulatory compliance in creating effective medical technologies.